News
The first live OIS program in almost two years, OIS Retina@ASRS, was as much an update on what was portrayed as a robust innovation ecosystem…
Read More
In the wake of the retirement of Judy Gordon, DVM (see related article here), three principals of the company she founded in 1998, ClinReg Consulting…
Read More
Harrow Health is a pharmaceutical maker with a portfolio of healthcare businesses focused on ophthalmology medications used in surgery as well as for dry eye,…
Read More
The live and in-person summit showcasing innovation in retina, OIS Retina@ASRS, will be held in San Antonio, Texas, on October 7, a day before the…
Read More
Despite a sharp dive in its stock price a day after reporting mixed topline results from two Phase III clinical trials of its lead candidate…
Read More
PODCAST EPISODE 297 Click here to watch the video version of this podcast. Damon Burrows isn’t a scientist. And he didn’t start IACTA Pharmaceuticals, an…
Read More
Judy Gordon, DVM, is not a job-hopper. When Laguna Beach, Calif.-based ClinReg Consulting Services, a company she founded in 1998, announced her retirement in March,…
Read More
First-in-class drugs are being investigated to treat two etiologies of dry eye disease (DED)—meibomian gland dysfunction (MGD) and Demodex blepharitis—both highly prevalent conditions for which…
Read More
The ocular allergy space has seen some renewed interest lately, with Food and Drug Administration approval of Santen Pharmaceutical’s new drug for vernal keratoconjunctivitis (VKC)…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")